Allison Transmission Holdings, Inc. — 7.0/10 — $117.06

Allison Transmission is the dominant manufacturer of fully automatic transmissions for medium- and heavy-duty commercial vehicles (Class 5-8), holding approximately 80% of the North American market. The company serves four primary end markets: NA On-Highway (trucks, buses, RVs; ~55-60% of revenue), Defense (~10-15%), Outside North America (~20-25%), and Off-Highway/Service Parts (~15-20%). FY2025 revenue was $3.01B with net income of $623M and FCF of $661M (22% margin) -- capital-light, high-conversion economics.

Near-monopoly passed. Allison holds ~80% NA share in fully automatic transmissions for Class 5-8 trucks with pricing power of 250-400bps annually. Eaton Cummins is encroaching but has achieved minimal real adoption in vocational verticals where Allison is entrenched. The sole-source position delivers exceptional margins: 37.5% EBITDA through a -7% revenue decline, expanding +140bps even as the cycle turned down.

The key tension is cyclical trough + Dana integration vs. valuation discount and multiple upside levers. At 13.2x forward P/E, ALSN trades at roughly half the multiple of peers Eaton (27x) and Cummins (23x). The COO publicly stated ALSN should be trading north of $200 in three years (+70%). FY2025 saw the first EPS decline since COVID (-11.8% to $7.33), driven by NA On-Highway cyclical weakness (-6.7% revenue decline), but defense surged +26% to $267M and buybacks accelerated ($328M, shares down -25% since 2020).

Dana acquisition is the swing factor. The pending Dana deal adds ~$5.75B consolidated revenue but dilutes margins (37.5% to ~25% EBITDA) and raises leverage to ~3.0x (vs <2.0x target). Management guided 2026 assuming zero Dana synergies, no NA recovery, trough off-highway, and no defense prebuy -- every one represents upside. $120M synergy target is entirely excluded from guidance.

ALSN receives a composite score of 7.0/10, reflecting a hidden near-monopoly with exceptional margin resilience and elite FCF generation at a steep valuation discount to peers, offset by cyclical trough headwinds and Dana integration execution risk.

Bull case ($175-200+): NA On-Highway cycle recovers (Class 8 orders already +130% YoY in Mar 2026), Dana synergies exceed $120M target, defense continues accelerating on OMFV and international programs, and the market re-rates ALSN closer to industrial peer multiples. At 18x forward EPS of $10+ (consolidated with Dana synergies) = $180+. COO target of $200+ in 3 years implies further upside from operational execution.

Base case ($120-140): Legacy business stabilizes at trough levels, Dana integration proceeds on schedule with modest synergy capture. Defense grows mid-teens. Consolidated FCF $655-805M as guided. Multiple stays at 13-15x as market waits for integration proof points. Modest upside from current levels.

Bear case ($80-95): NA On-Highway downturn extends through 2027, Dana integration stumbles (cross-border complexity across 25 countries), leverage remains elevated at 3.0x+, tariffs destroy demand, and consolidated margins disappoint. Multiple compresses to 10-11x as the market prices integration risk.

Bottom line: Allison Transmission is a rare near-monopoly industrial trading at a deep discount with 37.5% EBITDA margins through a downturn, $661M FCF, and deliberately sandbagged guidance with multiple upside levers. The 7.0 score reflects strong marks on management (8) and contrarian sentiment (8) balanced against cyclical weakness and Dana integration risk (both 6). The asymmetry is compelling -- every assumption in 2026 guidance represents potential upside.

Key catalysts and monitoring points:

• NA On-Highway order recovery: Class 8 orders surged +130% YoY in March 2026. Watch for sustained order momentum through Q2-Q3 2026 -- this is the single largest revenue driver (~51% of legacy revenue) and the primary cyclical swing factor.
• Dana integration milestones: $70M one-time integration costs expected. Track synergy capture pace against the $120M target (zero assumed in 2026 guide). Cross-border execution across 25 countries is the key risk.
• Defense contract awards: OMFV program (~3,000 vehicles with eGen Force) could be transformational. FY27 defense budget proposal +28%. Multi-year visibility from Turkey, Poland, and India programs.
• Deleveraging pace: Leverage at ~3.0x post-Dana vs management target of <2.0x. Speed of deleveraging will determine capital allocation flexibility (buybacks have been the primary shareholder return mechanism).
• Consolidated margin trajectory: Legacy 37.5% EBITDA dilutes to ~25% with Dana. Track quarterly progression -- any margin outperformance signals faster synergy capture.
• Analyst coverage expansion: Only 5-9 analysts cover the stock (Oppenheimer $135, Citi $130). Consensus is just beginning to catch up. New initiations would signal broader institutional discovery.
• International growth: Record $507M in FY2025. India expansion on track. Monitor for sustained double-digit international growth which management has targeted.
• Eaton Cummins competitive threat: Automated manual transmission encroachment remains the structural bear case. Track any vocational vertical share losses.

For the full analysis, see the Business Model, Financials, and Valuation pages.

Accumulate -- Allison is a hidden near-monopoly at 13x forward P/E with 37.5% EBITDA margins through a cyclical trough, deliberately sandbagged 2026 guidance, and defense growth accelerating. The stock at $117.06 is up ~54% from its 52-week low of $76.01 but still trades near its 50-day average ($116.01) and well above its 200-day ($96.56), indicating the trend has turned but is not overextended.

The business quality is clear: ~80% NA automatic transmission market share, 37.5% EBITDA margin expanding through a downturn, $661M FCF at 22% margin, -25% share count reduction since 2020, and 6 consecutive dividend increases. Defense revenue surged +26% to $267M with multi-year program visibility. The COO publicly targets $200+ in three years.

What would change the recommendation up: (1) NA On-Highway orders sustain recovery through Q2-Q3 2026, confirming cycle turn. (2) Dana synergies track ahead of $120M target in early quarters. (3) OMFV or other defense awards accelerate the defense revenue ramp. (4) Analyst initiations broaden coverage beyond 5-9 analysts, catalyzing institutional discovery.

What would change the recommendation down: (1) NA On-Highway downturn extends into 2027 with order cancellations reversing March momentum. (2) Dana integration costs exceed $70M or synergies fall short, keeping leverage elevated above 3.0x. (3) Eaton Cummins gains meaningful share in vocational verticals. (4) Tariff-driven demand destruction compounds the cyclical downturn. (5) Consolidated margins come in materially below the ~25% EBITDA blended target.